OQROGet OQRO Pro
Insider trade

Entrada Therapeutics (TRDA)Officer sold ~$2K

Natarajan Sethuraman, Officer at Entrada Therapeutics, sold ~$2K of Entrada Therapeutics shares.

~$2K
Approx. value · 100 sh @ $20.00
161K
Holds after · shares reported
Traded
Nov 29, 2024
Filed
Dec 3, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 16, 2024InsiderOfficer sold ~$11K of TRDA shares in the open market
  2. Nov 4, 2024InsiderOfficer sold ~$13K of TRDA shares in the open market
  3. Nov 5, 2024InsiderOfficer sold ~$94K of TRDA shares in the open market
  4. Nov 6, 2024Insider · 1 personInsiders: 2 sales (~$232K)
  5. Nov 11, 2024Insider · 2 peopleInsiders: 2 sales (~$201K)
  6. Nov 13, 2024InsiderOfficer sold ~$54K of TRDA shares in the open market
  7. Nov 29, 2024 · this disclosureInsiderOfficer sold ~$2K of TRDA shares in the open market

What came next

  1. Nov 29, 2024InsiderCFO sold ~$20K of TRDA shares in the open market
  2. Dec 2, 2024Insider · 2 peopleInsiders: 2 sales (~$183K)
  3. Dec 3, 2024InsiderOfficer sold ~$236K of TRDA shares in the open market
  4. Dec 10, 2024Insider · 2 peopleInsiders: 2 sales (~$953K)
  5. Dec 11, 2024Insider · 2 peopleInsiders: 2 sales (~$882K)
  6. Mar 17, 2025InsiderCFO sold ~$19K of TRDA shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Entrada Therapeutics

For Entrada Therapeutics, OQRO holds 33 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TRDA page.

Other recent filings by Natarajan Sethuraman, President, Research & Develop.

The full history of Natarajan Sethuraman, President, Research & Develop. is on the profile page.

How this filing works

Other disclosures at Entrada Therapeutics

Everything OQRO holds on this company is on its TRDA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data